Company: CDLX
Filing Date: 2025-04-03
Form Type: ARS
Source: 0001666071-25-000048
Chunk: 145

Company: Cardlytics, Inc.
Filing Date: 2025-04-03
Form: ARS
Chunk 145
---
2.5 million and $1.4 million, respectively, of stock-based compensation expense for software development. Restricted Stock Units We grant restricted stock units ("RSUs") to employees and our non-employee directors. The following table summarizes changes in RSUs, inclusive of performance-based RSUs: Shares (in thousands) Weighted-Average Grant Date Fair Value Per Share Weighted-Average Remaining Contractual Term (in years) Unamortized Compensation Costs (in thousands) Unvested - December 31, 2023 5,485 $ 15.70 Granted 4,949 9.65 Vested (3,503) 13.30 Forfeited (2,424) 11.47 Unvested - December 31, 2024 4,507 $ 13.20 1.20 $ 43,710 Shares (in thousands) Weighted-Average Grant Date Fair Value Per Share Weighted-Average Remaining Contractual Term (in years) Unamortized Compensation Costs (in thousands) Unvested - December 31, 2022 5,956 $ 25.43 Granted 3,560 7.19 Vested (2,947) 19.51 Forfeited (1,084) 31.66 Unvested - December 31, 2023 5,485 $ 15.70 2.01 $ 68,092 94

Shares (in thousands) Weighted-Average Grant Date Fair Value Per Share Weighted-Average Remaining Contractual Term (in years) Unamortized Compensation Costs (in thousands) Unvested - December 31, 2021 2,294 $ 60.58 Granted 6,182 24.74 Vested (984) 49.15 Forfeited/canceled (1,536) 59.94 Unvested - December 31, 2022 5,956 $ 25.43 2.93 $ 116,941 Service-based Restricted Stock Units During the year ended December 31, 2024, we granted 4,948,914 RSUs to employees and non-employee directors, which have vesting periods ranging from vesting immediately to vesting in four years. Subsequent to December 31, 2024, we granted 725,800 RSUs to employees, which have vesting periods ranging from eighteen months to two years. The unamortized stock-based compensation expense